DECITABINE

作品数：42被引量：73H指数：5
导出分析报告
相关领域：医药卫生更多>>
相关作者：王琳许小平曹蕾张浩朱尔佳更多>>
相关机构：台湾神隆股份有限公司复旦大学广东药学院连云港杰瑞药业有限公司更多>>
相关期刊：《Cellular & Molecular Immunology》《当代医学》《药学进展》《Oncology and Translational Medicine》更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Current Medical Sciencex
共 条 记 录，以下是1-3
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Chidamide,Decitabine,Cytarabine,Aclarubicin,and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia:A Retrospective Study from a Single-Center
《Current Medical Science》2023年第6期1151-1161,共11页Fan-cong KONG Ling QI Yu-lan ZHOU Min YU Wen-feng HUANG Fei LI 
the National Natural Science Foundation of China(No.81960043 and No.81600180);Natural Science Foundation of Jiangxi Province(No.20192ACB20030 and No.20203BBGL73197);Science and Technology Innovation Base Construction Project of Jiangxi Province(No.20212BCG74001 and No.20211ZDG02006).
Objective Preclinical evidence and clinical trials have suggested synergistic effects of epigenetic modifiers in combination with cytotoxic agents for the treatment of leukemia.However,their efficacy in patients with ...
关键词：relapsed/refractory acute myeloid leukemia histone deacetylase inhibitor DNA methyltransferase inhibitor salvage therapy 
Platelet Doubling After First Decitabine Cycle Predicts Response and Survival of Myelodysplastic Syndrome Patients被引量：1
《Current Medical Science》2022年第1期77-84,共8页Ping-fan LU Li-nan DENG Fan-kai MENG Ying WANG Min XIAO Deng-ju LI 
This work was supported by the National Natural Science Foundation of China(No.81770168 and No.81570110).
Objective:Although the effect of decitabine on myelodysplastic syndrome(MDS)has been demonstrated,merely a proportion of patients respond to therapy,and no well-recognized predictors have been identified.This study wa...
关键词：platelet doubling DECITABINE RESPONSE SURVIVAL myelodysplastic syndrome 
AIC AR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity
《Current Medical Science》2020年第5期871-878,共8页Xiao-ying ZHU Wen LIU Hai-tao LIANG Ling TANG Ping ZOU Yong YOU Xiao-jian ZHU 
Although the advent of tyrosine kinase inhibitors(TKIs)has dramatically improved the survival of patients with chronic myeloid leukaemia(CML),acquired drug resistance and TKI-insensitive leukaemic stem cells(LSCs)rema...
关键词：chronic myeloid leukaemia mitochondrial activity 5-aminoimidazole-4-carboxamide ribotide(AICAR) DECITABINE 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部